V3 Biomed provides woundcare providers and practices with the best-in-class CTP & Skin Sub technologies & tools. We help you dramatically improve patient outcomes, workflow efficiency, and compliance.
With access to every leading processor of CTPs & advanced grafts, we are able to ensure
you have the best available solution no matter your scenario or industry volatility.
Innovamatrix AC is a shelf-stable FDA cleared device Placental Xenograft. Non-oriented allowing for is non-oriented allowing for easier application.
Request InfoDermacyte is a Single Layer, shelf stable, Placental Tissue Allograft listed on Medicare's National ASP File. Dermacyte is non-oriented allowing for easier application.
Request InfocarePATCH™ is a Dual Layer shelf-stable Placental Tissue Allograft Graft listed on Medicare's National ASP File. carePATCH™ is non-oriented allowing for easier application.
Request InfoWith the ever-changing woundcare landscape, a trusted source for Cellular or Tissue based Products (CTPs) is critical for every woundcare practice.
Get exclusive access to the highest quality CTPs, Skin Subs, & Grafts
Optimize your administrative & clinical performance at the same time
Consulting and guidance on every intersection of CTPs in your practice
We have exclusively partnered with Patient Flows to build a software and suite of apps/ Solving real problems that providers and staff deal with every day. We build a custom App for each practice we onboard based on their unique needs and goals This App dramatically reduces the time it takes to complete CTP associated admin tasks, while ensuring better compliance & accuracy of data.
All your CTPs. All of their associated admin tasks. All in One App.
Fully HIPAA Encrypted App accessible on any Phone, Tablet, Desktop, or laptop
Verify Benefits, Order & Track Utilization. All in a fraction of the time you take now
V3 helped us source the best regenerative products in both sports med and woundcare. Their guidance helped us elevate our clinical outcomes and financially optimize our treatment offering.
Dr. Benji Tehrani
Clint and the entire team at V3 have opened so many doors for us. Not only in the realm of Skin subs (which have been amazing for our patients), but as a start up business they helped AZ Wound navigate though the complexities of billing and marketing.
Yadminder Dhillon MD
Clint & his team at V3 have been an amazing asset here for our clinic. They've got a lot of product knowledge and ability to get the best pricing. I highly recommend that you reach out to them if you are a medical facility utilizing regenerative medicine. Clint's an amazing human being and I can vouch for them any day.
Dr. Joaquin Rosado
We are a small collective of believers and medical professionals looking to change how practices source, leverage and utilize regenerative med technologies.
Clint Cochrane
Founder & CEO
For just under a decade Clint has been working to build one of the most reliable regenerative medicine suppliers in the nation that strives for truth over marketing angles. A patient himself, regenerative medicine helped save him from additional shoulder surgeries after a career ending football injury. This sent him on a mission to bring the right regenerative tech to the mainstream. Clint spends his time ensuring V3's partners and customers have access to the best regenerative tech the world has to offer.
Jack Nykaza
Partner & Practice Lead
Jack Nykaza has lead multiple teams to develop offering across health and wellness to real estate. Jack specializes in high touch, personalized consultation and brings V3's promise of modernized medical supplies to life.
Bill Cochrane
Chief Commercialization Officer
Bill has committed himself to family, community, and working with breakthrough technologies that improve people's quality of life for over 30 years. He brings extensive leadership expertise from his executive positions in Fortune 500 firms, startups, fire service, and EMS as well as 15 years of expertise in the placental tissue industry. As the son of a paramedic/firefighter whose life was cut short by lung disease, his mission continues to be identifying and bringing legitimate and impactful regenerative options to patients before it’s too late